Heska Corp (HSKA) Holdings Lifted by Bank of New York Mellon Corp

Bank of New York Mellon Corp grew its position in Heska Corp (NASDAQ:HSKA) by 110.1% in the 4th quarter, Holdings Channel reports. The firm owned 210,669 shares of the medical research company’s stock after buying an additional 110,391 shares during the period. Bank of New York Mellon Corp’s holdings in Heska were worth $16,897,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Schwab Charles Investment Management Inc. boosted its holdings in shares of Heska by 194.7% in the third quarter. Schwab Charles Investment Management Inc. now owns 31,215 shares of the medical research company’s stock valued at $2,750,000 after acquiring an additional 20,624 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Heska by 26.0% in the third quarter. Dimensional Fund Advisors LP now owns 151,460 shares of the medical research company’s stock valued at $13,342,000 after acquiring an additional 31,286 shares in the last quarter. Wells Fargo & Company MN boosted its holdings in Heska by 40.2% during the third quarter. Wells Fargo & Company MN now owns 141,423 shares of the medical research company’s stock worth $12,458,000 after buying an additional 40,532 shares in the last quarter. Atlantic Trust Group LLC bought a new stake in Heska during the third quarter worth approximately $16,059,000. Finally, California Public Employees Retirement System boosted its holdings in Heska by 16.5% during the third quarter. California Public Employees Retirement System now owns 14,533 shares of the medical research company’s stock worth $1,280,000 after buying an additional 2,053 shares in the last quarter. Hedge funds and other institutional investors own 85.21% of the company’s stock.

How to Become a New Pot Stock Millionaire

Shares of Heska stock opened at $77.96 on Friday. The firm has a market cap of $570.35, a P/E ratio of 59.51, a P/E/G ratio of 2.16 and a beta of 0.82. Heska Corp has a 1-year low of $56.59 and a 1-year high of $115.00.

Heska (NASDAQ:HSKA) last issued its quarterly earnings results on Wednesday, February 28th. The medical research company reported $0.63 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.56 by $0.07. The business had revenue of $36.04 million during the quarter, compared to the consensus estimate of $40.56 million. Heska had a net margin of 7.53% and a return on equity of 16.23%. The firm’s quarterly revenue was down 8.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.46 EPS. sell-side analysts forecast that Heska Corp will post 1.95 EPS for the current fiscal year.

A number of brokerages recently weighed in on HSKA. BidaskClub upgraded shares of Heska from a “sell” rating to a “hold” rating in a report on Friday, March 16th. TheStreet cut shares of Heska from a “b-” rating to a “c+” rating in a report on Friday, March 9th. Canaccord Genuity restated a “buy” rating and set a $95.00 target price on shares of Heska in a report on Thursday, March 1st. B. Riley reduced their target price on shares of Heska from $93.00 to $77.00 and set a “neutral” rating for the company in a report on Thursday, March 1st. Finally, Sidoti upgraded shares of Heska from a “neutral” rating to a “buy” rating and set a $94.00 target price for the company in a report on Monday, February 5th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the stock. Heska has an average rating of “Hold” and a consensus target price of $104.08.

TRADEMARK VIOLATION WARNING: This article was first posted by Ticker Report and is owned by of Ticker Report. If you are viewing this article on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The original version of this article can be viewed at https://www.tickerreport.com/banking-finance/3298301/heska-corp-hska-holdings-lifted-by-bank-of-new-york-mellon-corp.html.

About Heska

Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.

Want to see what other hedge funds are holding HSKA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Heska Corp (NASDAQ:HSKA).

Institutional Ownership by Quarter for Heska (NASDAQ:HSKA)

Receive News & Ratings for Heska Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

$3.95 Billion in Sales Expected for Kohl’s  This Quarter
$3.95 Billion in Sales Expected for Kohl’s This Quarter
$0.50 EPS Expected for Bitauto Hldg Ltd  This Quarter
$0.50 EPS Expected for Bitauto Hldg Ltd This Quarter
Inogen  Expected to Post Quarterly Sales of $62.60 Million
Inogen Expected to Post Quarterly Sales of $62.60 Million
Steem  Trading Up 13.1% Over Last Week
Steem Trading Up 13.1% Over Last Week
BitAsean  Market Capitalization Achieves $88,048.00
BitAsean Market Capitalization Achieves $88,048.00
C R Bard  Earns Coverage Optimism Rating of 0.16
C R Bard Earns Coverage Optimism Rating of 0.16


© 2006-2018 Ticker Report. Google+.